CTI BioPharma
-
Ticker
CTIC
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Seattle, Washington
Cell Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing novel agents that seek to improve the safety and efficacy of existing standard-of-care cancer treatments, and those that may have unique, new mechanisms to kill cancer cells.
REPORT RATINGS
4.8 / 5.0 (206)
CTI BioPharma reports have an aggregate usefulness score of 4.8 based on 206 reviews.
CTI BioPharma
Most Recent Annual Report
MOST RECENT
2022 Annual Report and Form 10K
Older/Archived Annual Reports